What Affects Willingness to Self-manage a Pessary?

February 28, 2023 updated by: Manchester University NHS Foundation Trust

Understanding Factors Which Affect Willingness to Self-manage a Pessary for Pelvic Organ Prolapse: A Mixed Methods Study Aiming to Improve Access to Pessary Self-management.

Pessary self-management is defined as the patient's ability to remove and reinsert their pessary themselves at home. Previous research has suggested that some women may prefer being able to remove and reinsert their pessary as they wish rather than wait for clinic appointments. At the moment, not enough is known about pessary self-management, particularly what makes someone more or less likely to try pessary self-management. The investigators would like to understand this better to try to help women overcome barriers they might face. This study aims to collect data via both questionnaires and interviews to explore willingness to self-manage a pessary. Using findings from the questionnaires and interviews, a group of women who use pessaries and healthcare professionals who provide pessary care will work together to develop a better way to support women to feel able and willing to manage their pessary in future.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

132

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Manchester, United Kingdom, M13 9WU
        • Recruiting
        • Manchester University NHS Foundation Trust
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Pessary using women and pessary practitioners

Description

Quantitative phase inclusion criteria

  • Willing and able to give implied consent by completion of the questionnaire
  • Female
  • Over the age of 18 years
  • Have retained a pessary for pelvic organ prolapse for a minimum of two weeks
  • Able to speak and understand English
  • Use a ring, shaatz, cube or inflatable pessary

Qualitative phase inclusion criteria

  • Willing and able to give informed consent
  • Female
  • Over the age of 18 years
  • Have retained a pessary for pelvic organ prolapse for a minimum of two weeks
  • Speak English or, for those whose first or preferred language is a language other than English, speak a language there is an available interpreter for

Intervention development phase inclusion criteria Pessary using women

  • Willing and able to give informed consent
  • Female
  • Over the age of 18 years
  • Have retained a pessary for pelvic organ prolapse for a minimum of two weeks
  • Speak English Pessary practitioners
  • Willing and able to give informed consent
  • Provide regular pessary care as part of clinical role (defined as insertion or removal of a woman's pessary on a minimum of a monthly basis)
  • Speak English

Pilot phase inclusion criteria

  • Willing and able to give informed consent, review the intervention and provide written and/or verbal feedback.
  • Female
  • Over the age of 18 years
  • Have retained a pessary for pelvic organ prolapse for a minimum of two weeks
  • Speak English
  • Have no previous experience self-managing a pessary (defined as never having removed or inserted their pessary, or received any pessary self-management teaching or support from a healthcare professional)

Exclusion Criteria:

Quantitative phase exclusion criteria

  • Lacking capacity to give implied consent by completion of the questionnaire
  • Has a first or preferred language that is not English
  • Use a shelf, gell-horn or donut pessary

Qualitative phase exclusion criteria

  • Lacking capacity to give informed consent
  • First or preferred language that is not English or a language there is an available interpreter for

Intervention development phase exclusion criteria Pessary using women

  • Lacking capacity to give informed consent
  • Does not speak English Pessary practitioners
  • Lacking capacity to give informed consent
  • Does not speak English
  • Does not provide pessary care at a minimum of a monthly basis

Intervention pilot exclusion criteria

  • Lacking capacity to give informed consent, review the intervention and provide written and/or verbal feedback.
  • Does not speak English
  • Have prior experience self-managing a pessary (defined as previously removing or inserting their pessary, or receiving any pessary self-management teaching or support from a healthcare professional)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Quantitative phase
Pessary using women
Qualitative phase
Pessary using women
Intervention development phase
Pessary using women and pessary practitioners
Pilot phase
Pessary using women
Uncertain what intervention will be co-created

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Willingness to self-manage a pessary
Time Frame: Through study completion, an average of 1 appointment (1 day)
Women will be asked whether they are willing or not to self-manage a pessary for prolapse. This will be a binary yes, no or not sure answer.
Through study completion, an average of 1 appointment (1 day)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Through study completion, an average of 1 appointment (1 day)
Full years since birth
Through study completion, an average of 1 appointment (1 day)
Pessary
Time Frame: Through study completion, an average of 1 appointment (1 day)
Type and size of pessary in situ
Through study completion, an average of 1 appointment (1 day)
Length of pessary management
Time Frame: Through study completion, an average of 1 appointment (1 day)
Total months pessary used for
Through study completion, an average of 1 appointment (1 day)
Comorbidities
Time Frame: Through study completion, an average of 1 appointment (1 day)
Free text data for participant to report diagnosed health conditionns
Through study completion, an average of 1 appointment (1 day)
Self-management experience
Time Frame: Through study completion, an average of 1 appointment (1 day)
The woman will be asked whether she has previously removed or inserted her pessary
Through study completion, an average of 1 appointment (1 day)
Self-management status
Time Frame: Through study completion, an average of 1 appointment (1 day)
The woman will be asked whether she is currently self-managing her pessary (defined as removing and inserting it independently in between clinic appointments)
Through study completion, an average of 1 appointment (1 day)
Ethnicity
Time Frame: Through study completion, an average of 1 appointment (1 day)
Ethnic groups in accordance with UK government agreed list of ethnicities
Through study completion, an average of 1 appointment (1 day)
Post code
Time Frame: Through study completion, an average of 1 appointment (1 day)
Post code at home address to determine deprivation of home address in accordance with UK government index of deprivation
Through study completion, an average of 1 appointment (1 day)
Education status
Time Frame: Through study completion, an average of 1 appointment (1 day)
Women will be asked to report their highest level of education
Through study completion, an average of 1 appointment (1 day)
Female genital self-image score (FGSIS)
Time Frame: Through study completion, an average of 1 appointment (1 day)
Women will also be asked to complete the Female Genital Self-Image Scale (FGSIS-4), a reliable and validated 4-item questionnaire which measures women's attitude and beliefs about their genitals (Herbenick and Reece, 2010). Scores in the FGSIS-4 range between 4-16, with a mean score of 12 in a nationally representative population of over 2000 American women (Herbenick et al., 2011). Herbenick et al. (2011) have not determined a binary score for high and low FGSIS, however for the purpose of this study, a score of eight or less will indicate low FGSI, whereas more than eight will indicate high FGSI. To score eight or less, a participant must disagree with all four statements describing genital self-image therefore this is deemed to accurately represent FGSIS-4.
Through study completion, an average of 1 appointment (1 day)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 25, 2022

Primary Completion (Anticipated)

March 1, 2024

Study Completion (Anticipated)

March 1, 2024

Study Registration Dates

First Submitted

August 19, 2022

First Submitted That Met QC Criteria

February 28, 2023

First Posted (Actual)

March 1, 2023

Study Record Updates

Last Update Posted (Actual)

March 1, 2023

Last Update Submitted That Met QC Criteria

February 28, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • B01328

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to make IPD available to other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prolapse; Female

Clinical Trials on Uncertain what intervention will be co-created

3
Subscribe